Financial reports
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
2 Jun 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
2 May 23
NT 10-K
Notice of late annual filing
31 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
27 Feb 24
8-K
Entry into a Material Definitive Agreement
22 Feb 24
8-K
Entry into a Material Definitive Agreement
7 Dec 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Nov 23
8-K
Qualigen Therapeutics Provides Corporate Update for Third Quarter and To Date 2023
14 Nov 23
8-K
Qualigen Therapeutics Announces First Patient Dosed in the Phase 1a Clinical Trial of QN-302 for Treatment of Advanced or Metastatic Solid Tumors
8 Nov 23
8-K
Regulation FD Disclosure
17 Oct 23
8-K
Entry into a Material Definitive Agreement
28 Sep 23
8-K
Results of Operations and Financial Condition
15 Aug 23
8-K
Departure of Directors or Certain Officers
4 Aug 23
Registration and prospectus
S-1/A
IPO registration (amended)
2 Oct 23
424B3
Prospectus supplement
29 Sep 23
POS AM
Prospectus update (post-effective amendment)
1 Sep 23
S-1
IPO registration
13 Jun 23
S-3
Shelf registration
30 Dec 22
S-3
Shelf registration
29 Jul 22
S-3
Shelf registration
17 Jun 22
S-8
Registration of securities for employees
10 Jan 22
424B5
Prospectus supplement for primary offering
1 Dec 21
424B5
Prospectus supplement for primary offering
18 Dec 20
Proxies
DEF 14A
Definitive proxy
2 Jun 23
PRE 14A
Preliminary proxy
15 May 23
DEFA14A
Additional proxy soliciting materials
28 Sep 22
DEFA14A
Additional proxy soliciting materials
13 Jul 22
DEF 14A
Definitive proxy
13 Jul 22
PRE 14A
Preliminary proxy
1 Jul 22
DEF 14A
Definitive proxy
29 Apr 21
DEFA14A
Additional proxy soliciting materials
26 Apr 19
DEF 14A
Definitive proxy
26 Apr 19
DEFA14A
Additional proxy soliciting materials
25 May 18
Other
EFFECT
Notice of effectiveness
8 Sep 23
EFFECT
Notice of effectiveness
6 Jan 23
CORRESP
Correspondence with SEC
3 Jan 23
UPLOAD
Letter from SEC
3 Jan 23
EFFECT
Notice of effectiveness
8 Aug 22
CORRESP
Correspondence with SEC
3 Aug 22
UPLOAD
Letter from SEC
3 Aug 22
EFFECT
Notice of effectiveness
30 Jun 22
CORRESP
Correspondence with SEC
27 Jun 22
UPLOAD
Letter from SEC
24 Jun 22